DrSally Coggins

- Pathogens within peritonitis: Canvassing co-infection and evaluating PCR utility for diagnostic refinement of FIP effusions
- Genomic surveillance and diagnosis of Australian cats with feline infectious peritonitis through next-generation sequencing approaches
- Investigation of tryptophan and kynurenines as predictive markers to monitor response to antiviral treatment in cats with feline infectious peritonitis
- Determining the utility of acute phase proteins in assessing the clinical progress of oral GS-441524 treatment for naturally occurring feline infectious peritonitis in domestic cats
- Genetic susceptibility of cats to feline infectious peritonitis
- Population pharmacokinetic modelling approach to determine the utility of therapeutic drug monitoring for cats with FIP treated with remdesivir and / or GS-441524
- Long term outcome survey - "where are they now" A retrospective survey of the long-term outcomes for 307 cats treated for FIP between 2020 - 2022.
- Feline infectious peritonitis treatment guideline development - International Society of Companion Animal Infectious Diseases, utilising GRADE methodology for guideline development
- Pharmacokinetics of New Zealand compounded remdesivir in cats with feline infectious peritonitis
- Feline leukaemia virus (FeLV) infectious in domestic pet cats in Australia and New Zealand: Guidelines for diagnosis, prevention and management
- Virus isolation as a tool to investigate molecular diversity and pathogenesis of important feline viral infections including feline calicivirus and feline coronavirus